Showing results (1-10 of 64) with videos related to
Sort By:
Pageof 7
Blood|March 8, 2024
DNA damage response defects in hematologic malignancies: mechanistic insights and therapeutic strategiesMarwan Kwok, Angelo Agathanggelou, Tatjana StankovicCancers|September 28, 2021
Targeting the p53 Pathway in CLL: State of the Art and Future PerspectivesMarwan Kwok, Angelo Agathanggelou, Nicholas Davies, et al.Cancers|January 21, 2022
Correction: Kwok et al. Targeting the p53 Pathway in CLL: State of the Art and Future Perspectives. Cancers 2021, 13, 4681Marwan Kwok, Angelo Agathanggelou, Nicholas Davies, et al.Lancet (London, England)|August 28, 2015
Synthetic lethality in chronic lymphocytic leukaemia with DNA damage response defects by targeting the ATR pathwayMarwan Kwok, Nicholas Davies, Angelo Agathanggelou, et al.Srpski Arhiv Za Celokupno Lekarstvo|August 30, 2008
Molecular mechanisms involved in chemoresistance in paediatric acute lymphoblastic leukaemiaTatjana Stankovic, Eliot MarstonLeukemia & Lymphoma|August 3, 2013
The role of ATM mutations and 11q deletions in disease progression in chronic lymphocytic leukemiaTatjana Stankovic, Anna SkowronskaBioessays : News and Reviews in Molecular, Cellular and Developmental Biology|February 28, 2004
Rac1 and Rac2 GTPases in haematopoiesisVictoria J Weston, Tatjana StankovicFrontiers in Oncology|January 3, 2022
Clonal Evolution of High-Risk Chronic Lymphocytic Leukemia: A Contemporary PerspectiveMarwan Kwok, Catherine J WuBlood|November 14, 2015
ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cellsMarwan Kwok, Nicholas Davies, Angelo Agathanggelou, et al.Oncotarget|May 13, 2017
Dynamic changes in clonal cytogenetic architecture during progression of chronic lymphocytic leukemia in patients and patient-derived murine xenograftsNicholas J Davies, Marwan Kwok, Clive Gould, et al.Pageof 7